<DOC>
	<DOCNO>NCT03039699</DOCNO>
	<brief_summary>The purpose study obtain additional data efficacy safety Ergoferon treatment viral intestinal infection inpatient child</brief_summary>
	<brief_title>Clinical Trial Efficacy Safety Ergoferon Treatment Viral Intestinal Infections Children</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Trematode Infections</mesh_term>
	<criteria>1 . Patients sex aged 6 month 6 year , admit hospital infectious disease unit . 2 . Diarrhea ( watery diarrhea least 3 time day ) . 3 . CDS score ≥1 . 4 . The first 48 hour onset first diarrhea episode . 5 . Start study treatment ( Ergoferon/Placebo ) within 12 hour start standard hospital therapy . 6 . Availability patient information sheet ( Informed Consent form ) sign patient 's parents/adopters confirm child 's participation clinical trial sign one parent/adopter patient . 1 . Suspected bacterial intestinal infection . 2 . Suspected infectious disease affect organ system ( e.g . pneumonia , meningitis , sepsis , otitis medium , urinary tract infection , etc. ) . 3 . Severe intestinal infection . 4 . Severe dehydration ( CDS score ≥7 ) . 5 . Anuria ( acute kidney injury ) . 6 . Medical history prior diagnosis serious disease , include primary/secondary immunodeficient , oncological disease , diabetes mellitus , infantile cerebral palsy , mucoviscidosis/cystic fibrosis etc . 7 . Exacerbation decompensation chronic disease , include disease digestive system would affect patient 's ability participate clinical trial . 8 . Malabsorption syndrome , include congenital acquire lactose intolerance/lactase deficiency disaccharidase deficiency galactosemia . 9 . Allergy/ intolerance component medication use treatment . 10 . Course intake medicine list section `` Prohibited concomitant treatment '' 2 week prior enrollment trial . 11 . Participation clinical trial within 3 month prior enrollment study . 12 . Patients whose parents/adopters , investigator 's point view , fail comply observation requirement trial dose regimen study drug . 13 . Patient 's parents/adopters relate research staff clinical investigative site directly involve trial immediate family member researcher . The immediate family member include husband/wife , parent , child brother ( sister ) , regardless whether natural adopt . 14 . The patient 's parent/adopter work OOO `` NPF `` MATERIA MEDICA HOLDING '' ( i.e. , company 's employee , temporary contract worker appoint official responsible carry research ) immediate relative .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>